Optic Neuropathy and Blindness Associated With Crizotinib for Non–Small-Cell Lung Cancer With EML4-ALK Translocation
- 10 February 2015
- journal article
- case report
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (5) , e25-e26
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysisThe Lancet Oncology, 2011
- Targeting Anaplastic Lymphoma Kinase in Lung CancerClinical Cancer Research, 2011
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- Targeted therapy in non-small-cell lung cancer—is it becoming a reality?Nature Reviews Clinical Oncology, 2010
- Radiation-induced optic neuropathyJournal of Clinical Neuroscience, 2008
- Radiation-induced injury to the visual pathwayRadiotherapy and Oncology, 1994
- The effects of irradiation on the eye and optic nerveInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1983